Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2517 -0.1227%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: Hong Kong
  • Sector: Diversified
  • Industry: Holding Companies-Divers
  • Sub-Industry: Diversified Operations

China Renji Medical Group Ltd/Hong Kong

Add to Portfolio

648:HK

0.060 HKD 0.0000.00%

As of 04:01:04 ET on 05/25/2012.

Trading has been suspended for 648:HK

Snapshot for China Renji Medical Group Ltd/Hong Kong (648)

Open: 0.060 Day's Range: 0.060 - 0.060 Volume: 0 Bid: -
Previous Close: 0.060 52wk Range: 0.060 - 0.060 1-Yr Rtn: 0.00% Ask: -

Stock Chart for 648

No chart data available.
  • 648:HK 0.060
  • 1D
  • 1M
  • 1Y
0.060
Interactive 648 Chart

Previous Close

Key Statistics for 648

Current P/E Ratio (ttm) -
Estimated P/E (-) -
Earnings Per Share () (ttm) -0.0197
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 812.71
Shares Outstanding (M) 13,545.11
Enterprise Value (M HKD) (ttm) 869.03
Enterprise Value/EBITDA (ttm) 10.48
Price/Book (mrq) 1.8707
Price/Sale (ttm) 5.3362
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 08/29/2012
More 648 Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for 648

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)
More 648 Income Statement Data
  • Total Assets
  • Total Liabilities (M/HKD)
  • Debt to Assets (%)
More 648 Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/HKD)
More 648 Cash Flow Data

Company Profile & Key Executives for 648

China Renji Medical Group Limited, through its subsidiaries, manages and operates a network of medical centers specializing in the diagnosis and treatment of tumors and cancer in China.

Yu Chung Hang "Lucian"Chief Executive OfficerGuo Bao PingExecutive Director
More Company Profile & Key Executives for 648

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements